Circle Pharma
Edward Garmey is a seasoned medical executive with extensive experience in the biopharmaceutical industry. Currently serving as Consulting Chief Medical Officer at ProteinQure and Consulting Chief Medical Officer at ModeX Therapeutics Inc., Garmey also holds interim positions at Circle Pharma, Inc. and served as Interim CMO at HiFiBiO Therapeutics. Garmey is an established consultant with a focus on clinical drug development, leading CMO Consulting, Inc., and providing strategic guidance to various companies including GigaGen Inc. and ImmuneSensor Therapeutics. A visiting instructor in the Therapeutics Graduate Program at Harvard Medical School, Garmey has a medical degree from the Icahn School of Medicine at Mount Sinai and an AB from Harvard University.
This person is not in any offices
Circle Pharma
2 followers
Circle Pharma, Inc. initiated operations in June 2014 with seed funding from Pfizer, Inc. and Mission Bay Capital, LLP; we received additional seed funding from ShangPharma Investment Group Limited in November 2015. We recently raised Series B and Series C financing from The Column Group and NextTech Invest.